Skip to main content
Premium Trial:

Request an Annual Quote

ISB Expands Use of Lumera Technology to Cover Biomarker Detection Technology

NEW YORK (GenomeWeb News) — Lumera has expanded its agreement with the Institute for Systems Biology to focus on detection methods for a cancer biomarker array, the Bothell, Wash.-based company said today.
 
The expanded agreement builds on a February 2005 pact in whic ISB agreed to test Lumera's ProteomicProcessor system.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more